Severe PPH (≥ 1000 mL) · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in severe PPH ≥ 1000 mL compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Serious maternal morbidity · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in serious maternal morbidity compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Maternal death · women in the 3rd stage of labour undergoing a vaginal birth.
1 finding from 1 review
Frequency of PPH ≥ 500 mL · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous leads to lower PPH ≥ 500 mL compared with intramuscular oxytocin (high certainty).
1 finding from 1 review
Use of additional uterotonics · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in use of additional uterotonics compared with intramuscular oxytocin (low certainty).
1 finding from 1 review
Blood transfusion · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous leads to lower blood transfusion compared with intramuscular oxytocin (high certainty).
1 finding from 1 review
Hypotension · women in the 3rd stage of labour undergoing a vaginal birth.
Intravenous showed no clear difference in hypotension compared with intramuscular oxytocin (moderate certainty).
1 finding from 1 review
Clinical relapse · SSNS in children
Intravenous may leads to lower relapse at 6 months compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Continuing frequently relapsing or steroid‐dependent SSNS at 6 months · SSNS in children
Intravenous may leads to lower continuing frequently‐relapsing or steroid‐dependent SSNS at 6 months compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Relapse · SSNS in children
Intravenous showed no clear difference in relapse at end of study compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Mean relapse rate/patient/month · SSNS in children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: leucopenia · SSNS in children
Intravenous showed no clear difference in adverse events: leucopenia compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse events: hair loss · SSNS in children
Intravenous showed no clear difference in adverse events: hair loss compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse events: all infections · SSNS in children
Intravenous may leads to lower adverse events: all infections compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse event nausea and vomiting (0 to 24 hours) · SSNS in children
It is very uncertain whether intravenous changes adverse events: nausea and vomiting compared with oral cyclophosphamide (very low certainty).
1 finding from 1 review
Insertion failures · adults or children requiring fluid delivered by a parenteral route (one study testing insertion and the volume of fluid delivered in…
Intravenous may leads to higher insertion failures compared with intraosseous route (low certainty).
1 finding from 1 review
Volume of fluid infused · adults or children requiring parenteral access for infusion of fluids or medication
1 finding from 1 review
Time to infusion/placement · adults or children requiring fluid delivered by a parenteral route (one study testing insertion and the volume of fluid delivered in…
1 finding from 1 review
Dislodgement of device during infusion · adults or children requiring fluid delivered by a parenteral route (one study testing insertion and the volume of fluid delivered in…
Intravenous showed no clear difference in dislodgement of device during infusion compared with intraosseous route (low certainty).
1 finding from 1 review
Needlestick injuries · adults or children requiring fluid delivered by a parenteral route (one study testing insertion and the volume of fluid delivered in…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found